Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hemogenyx Pharmaceuticals Share News (HEMO)
HEMO Share
Price
HEMO Share
News
HEMO Share
Chat21
HEMO Share
Trades73
HEMO
Live RNS
HEMO Share
Charts
HEMO Level 2
Console
HEMO Live
Share Price
HEMO Broker
Ratings
HEMO Directors
Deals
HEMO Financial
Diary
HEMO
Fundamentals
HEMO Short
Positions
HEMO
Media
HEMO Company
Research
HEMO Company
Timeline
Share Price Information for Hemogenyx Pharmaceuticals (HEMO)
Last checked at -
Last checked at 
Intraday Hemogenyx Pharmaceuticals Share Chart
IN BRIEF: Hemogenyx Pharma second process qualification run successful
Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Successfully completes its second process qualification run of the end-to-end process for the manufacture of HEMO-CAR-T cells. The company says it was followed by analytical release tests to verify the quality of the manufactured cells. The run is the second of three identical manufacturing runs required by the US Food and Drug Administration for the submission of an investigational new drug application. The IND application is needed in order to commence phase one clinical trials of HEMO-CAR-T cells.
Current stock price: 1.59 pence, up 8.0% in London on Wednesday afternoon
12-month change: down 18%
By Harvey Dorset, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Latest HEMO News
- EARNINGS: Titon half-year loss widens; Seplat quarterly profit down
1 May 2026 - TRADING UPDATES: GenIP partners with Cardinal IP; Orosur drill results
28 Apr 2026 - WINNERS & LOSERS: Oracle Power shines; Ferrexpo output plunges
15 Apr 2026 - WINNERS & LOSERS: Tullow falls as oil down; Thungela swings to loss
23 Mar 2026 - EARNINGS AND TRADING: Asia Strategic "well-positioned" as loss narrows
10 Feb 2026 - LONDON MARKET MIDDAY: FTSE 100 dips as banks slide, mid-caps rise
10 Feb 2026 - SMALL-CAP WINNERS & LOSERS: Hemogenyx raises funds for phase I trials
10 Feb 2026 - Hemogenyx secures clearance for pediatric enrolment in leukemia trial
6 Oct 2025
Related News
EARNINGS: Titon half-year loss widens; Seplat quarterly profit down
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...
TRADING UPDATES: GenIP partners with Cardinal IP; Orosur drill results
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
WINNERS & LOSERS: Oracle Power shines; Ferrexpo output plunges
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.
Hemogenyx Pharmaceuticals News
EARNINGS: Titon half-year loss widens; Seplat quarterly profit down
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...
TRADING UPDATES: GenIP partners with Cardinal IP; Orosur drill results
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
WINNERS & LOSERS: Oracle Power shines; Ferrexpo output plunges
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.
WINNERS & LOSERS: Tullow falls as oil down; Thungela swings to loss
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday.
EARNINGS AND TRADING: Asia Strategic "well-positioned" as loss narrows
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
LONDON MARKET MIDDAY: FTSE 100 dips as banks slide, mid-caps rise
(Alliance News) - Stock prices in London were mixed at midday on Tuesday, with the FTSE 100 edging lower as investors weighed a busy flow of company n...
SMALL-CAP WINNERS & LOSERS: Hemogenyx raises funds for phase I trials
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.
Hemogenyx secures clearance for pediatric enrolment in leukemia trial
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukem...
Follow the stocks
